Apparent modulation of CD20 by rituximab: an alternative explanation.
Cragg
Mark S
MS
Bayne
Mike C
MC
Illidge
Timothy M
TM
Valerius
Thomas
T
Johnson
Peter W N
PW
Glennie
Martin J
MJ
D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000187:drug effects*; D015536:Down-Regulation / Q000187:drug effects; D006801:Humans; D015448:Leukemia, B-Cell / Q000188:drug therapy / Q000473:pathology; D000069283:Rituximab; D014407:Tumor Cells, Cultured
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab